BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li XQ, Guo YY, De W. DNA methylation and microRNAs in cancer. World J Gastroenterol 2012; 18(9): 882-888 [PMID: 22408346 DOI: 10.3748/wjg.v18.i9.882] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Mizoguchi A, Takayama A, Arai T, Kawauchi J, Sudo H. MicroRNA-8073: Tumor suppressor and potential therapeutic treatment. PLoS One 2018;13:e0209750. [PMID: 30589909 DOI: 10.1371/journal.pone.0209750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
2 Sharma P, Sharma R. miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy. Crit Rev Oncol Hematol. 2015;96:449-462. [PMID: 26257289 DOI: 10.1016/j.critrevonc.2015.07.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
3 Wei Z, Doria C, Liu Y. Targeted therapies in the treatment of advanced hepatocellular carcinoma. Clin Med Insights Oncol 2013;7:87-102. [PMID: 23761989 DOI: 10.4137/CMO.S7633] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sun K, Deng HJ, Lei ST, Dong JQ, Li GX. miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol 2013; 19(14): 2197-2207 [PMID: 23599646 DOI: 10.3748/wjg.v19.i14.2197] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
5 Wang J, Jiang Y, Yang A, Sun W, Ma C, Ma S, Gong H, Shi Y, Wei J. Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E-Deficient Mice. Biores Open Access 2013;2:118-27. [PMID: 23593564 DOI: 10.1089/biores.2012.0300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
6 Meng H, Han L, Hong C, Ding J, Huang Q. Aberrant lncRNA Expression in Multiple Myeloma. Oncol Res 2018;26:809-16. [PMID: 29212572 DOI: 10.3727/096504017X15123872205507] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
7 Miao X. Recent advances in understanding the role of miRNAs in exosomes and their therapeutic potential. Journal of Integrative Agriculture 2017;16:753-61. [DOI: 10.1016/s2095-3119(16)61530-7] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen YJ, Luo J, Yang GY, Yang K, Wen SQ, Zou SQ. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma. World J Gastroenterol 2012; 18(29): 3849-3861 [PMID: 22876037 DOI: 10.3748/wjg.v18.i29.3849] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
9 Langie SA, Koppen G, Desaulniers D, Al-Mulla F, Al-Temaimi R, Amedei A, Azqueta A, Bisson WH, Brown DG, Brunborg G. Causes of genome instability: the effect of low dose chemical exposures in modern society. Carcinogenesis. 2015;36 Suppl 1:S61-S88. [PMID: 26106144 DOI: 10.1093/carcin/bgv031] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 13.3] [Reference Citation Analysis]
10 Elsewify WAE, Hassan EA, Mekky MA, Abd El-Rehim ASE, Sayed ZEA, Abdel Malek MO, ElMelegy TTH, Sabry A. Usefulness of Circulating Methylated p16 as a Noninvasive Molecular Biomarker for Hepatitis C-Related Hepatocellular Carcinoma with Normal Serum Alpha-Fetoprotein Levels. Int J Gen Med 2020;13:147-55. [PMID: 32431531 DOI: 10.2147/IJGM.S249272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sun H, Shamy M, Costa M. Nickel and epigenetic gene silencing. Genes (Basel) 2013;4:583-95. [PMID: 24705264 DOI: 10.3390/genes4040583] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
12 Gaál Z, Oláh E. [MicroRNA-s and their role in malignant hematologic diseases]. Orv Hetil. 2012;153:2051-2059. [PMID: 23261993 DOI: 10.1556/oh.2012.29511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lai NS, Yu HC, Chen HC, Yu CL, Huang HB, Lu MC. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis. Clin Exp Immunol 2013;173:47-57. [PMID: 23607629 DOI: 10.1111/cei.12089] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 7.6] [Reference Citation Analysis]
14 Li X, Yang X, Fan Y, Cheng Y, Dong Y, Zhou J, Wang Z, Li X, Wang J. A ten-gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer. Genomics 2021;113:2032-44. [PMID: 33915245 DOI: 10.1016/j.ygeno.2021.04.035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Yan H, Sun J. Methylation status of WWOX gene promoter CpG islands in epithelial ovarian cancer and its clinical significance. Biomed Rep 2013;1:375-8. [PMID: 24648952 DOI: 10.3892/br.2013.86] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kuo CH, Ying SY. MicroRNA-mediated somatic cell reprogramming. J Cell Biochem 2013;114:275-81. [PMID: 22961769 DOI: 10.1002/jcb.24385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
17 Zhou D, Jiang X, Ding W, Zheng L, Yang L, Zheng C, Lu L. siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer. J Cancer Res Clin Oncol 2013;139:2057-70. [PMID: 24077839 DOI: 10.1007/s00432-013-1492-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Genç F, Kara M, Ünal Y, Uygur Küçükseymen E, Biçer Gömceli Y, Kaynar T, Tosun K, Kutlu G. Methylation of cation-chloride cotransporters NKCC1 and KCC2 in patients with juvenile myoclonic epilepsy. Neurol Sci 2019;40:1007-13. [PMID: 30759289 DOI: 10.1007/s10072-019-03743-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 Zelic R, Fiano V, Grasso C, Zugna D, Pettersson A, Gillio-Tos A, Merletti F, Richiardi L. Global DNA hypomethylation in prostate cancer development and progression: a systematic review. Prostate Cancer Prostatic Dis 2015;18:1-12. [PMID: 25384337 DOI: 10.1038/pcan.2014.45] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]